Author: Isla Wilson

Accessible Holidays in Australia 2026: Inclusive Accommodation, Coastal Destinations and Tourism Infrastructure

Accessible Holidays in Australia 2026: Inclusive Accommodation, Coastal Destinations and Tourism InfrastructureAccessible Holidays in Australia 2026: Inclusive Accommodation, Coastal Destinations and Tourism Infrastructure

Accessible Accommodation Is Becoming a Tourism Priority Australia’s accessible tourism industry is evolving as destinations recognise that successful holidays require more than wheelchair-friendly attractions. For travellers with disabilities, accessible accommodation,

Australia’s .6 Billion Long COVID Burden — Economic Fallout, Workforce Loss, and the Case for Urgent Investment

Australia’s $9.6 Billion Long COVID Burden — Economic Fallout, Workforce Loss, and the Case for Urgent InvestmentAustralia’s $9.6 Billion Long COVID Burden — Economic Fallout, Workforce Loss, and the Case for Urgent Investment

The Economic Shadow of the Pandemic While Australia’s national conversation around COVID-19 has largely shifted to discussions of “living with the virus,” the economic consequences of Long COVID continue to

First Nations Screen IP Goes Global: Inside Australia’s ,000 Co-Production Push at TIFF 2026

First Nations Screen IP Goes Global: Inside Australia’s $30,000 Co-Production Push at TIFF 2026First Nations Screen IP Goes Global: Inside Australia’s $30,000 Co-Production Push at TIFF 2026

A Strategic Investment in Indigenous Storytelling In May 2026, Screen Australia’s First Nations Department, in partnership with Screen Canberra, Screen NSW, Screen Queensland, Screen Tasmania, Screen Territory, Screenwest, the South

Pharmacogenomics in Australia 2026: When Your Genes Determine Which Antidepressant Works

Pharmacogenomics in Australia 2026: When Your Genes Determine Which Antidepressant WorksPharmacogenomics in Australia 2026: When Your Genes Determine Which Antidepressant Works

The Quiet Revolution in Prescription Medicine While precision oncology dominates headlines, a parallel genomic transformation is unfolding in Australia’s general practices and chemotherapy suites. Pharmacogenomics—the study of how genetic variation